Published in Am J Trop Med Hyg on July 01, 1984
Outbreak of viral hemorrhagic fever caused by dengue virus type 3 in Al-Mukalla, Yemen. BMC Infect Dis (2013) 0.98
Imported dengue virus serotype 3, Yemen to Italy, 2010. Emerg Infect Dis (2011) 0.97
Dengue outbreak in Hadramout, Yemen, 2010: an epidemiological perspective. Am J Trop Med Hyg (2012) 0.90
Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012. Emerg Infect Dis (2014) 0.84
Dengue in the Middle East and North Africa: A Systematic Review. PLoS Negl Trop Dis (2016) 0.75
Viral hemorrhagic fevers in the Tihamah region of the western Arabian Peninsula. PLoS Negl Trop Dis (2017) 0.75
Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med (1982) 4.16
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med (1982) 3.56
Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J Bacteriol (1987) 1.93
Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease. J Infect Dis (2000) 1.91
Emphysematous gastritis: case report and review. Rev Infect Dis (1990) 1.91
Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis (2001) 1.89
The compromised host and Legionnaires' disease. Ann Intern Med (1979) 1.83
Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med (1992) 1.69
The increasing importance of polymicrobial bacteremia. JAMA (1979) 1.58
Reduction in Legionella pneumophila through heat flushing followed by continuous supplemental chlorination of hospital hot water. J Infect Dis (1990) 1.51
Screening CT of the brain determined by CD4 count in HIV-positive patients presenting with headache. AJNR Am J Neuroradiol (2000) 1.43
Osteomyelitis of the pubis. Report of seven cases. JAMA (1982) 1.41
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin. Antimicrob Agents Chemother (1984) 1.39
Clinical studies of cefazolin and comparison with other cephalosporins. Antimicrob Agents Chemother (1973) 1.28
Listerial prosthetic valve endocarditis. Successful medical therapy. JAMA (1978) 1.24
Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J (1978) 1.15
In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother (1983) 1.11
Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy. J Infect Dis (1994) 1.09
Ceforanide: in vitro and clinical evaluation. Antimicrob Agents Chemother (1979) 1.08
The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol (1992) 1.04
Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis (1996) 1.03
In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones. J Antimicrob Chemother (1988) 1.02
Necrotizing cellulitis caused by Legionella micdadei. Am J Med (1992) 1.01
Identification of the heat-shock sigma factor RpoH and a second RpoH-like protein in Sinorhizobium meliloti. Microbiology (2001) 1.00
Legionnaires' disease. A cause of lung abscess. JAMA (1979) 0.99
Failure of probenecid to alter the pharmacokinetics of ceforanide. Antimicrob Agents Chemother (1981) 0.98
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother (1987) 0.98
The effect of inoculum, culture medium and antimicrobial combinations on the in-vitro susceptibilities of Legionella pneumophila. J Antimicrob Chemother (1981) 0.98
Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology (1993) 0.97
Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV. Scand J Infect Dis (1980) 0.96
In vitro susceptibility of Legionella pneumophila, serogroups I-IV. J Infect Dis (1979) 0.96
Failure of therapy in pseudomonas endocarditis: selection of resistant mutants. J Infect Dis (1986) 0.95
A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.92
High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes (1994) 0.91
Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin. J Antimicrob Chemother (1988) 0.89
Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH. J Clin Microbiol (1993) 0.88
Multiple small bowel perforations secondary to cytomegalovirus in a patient with acquired immunodeficiency syndrome. Henry Ford Hosp Med J (1987) 0.88
Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS (1995) 0.88
Infected false aneurysms of the femoral artery in intravenous drug addicts. Rev Infect Dis (1989) 0.86
Direct immunofluorescence in the diagnosis of Legionnaires' disease. Chest (1981) 0.86
C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. J Immunol (1987) 0.86
Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila. Antimicrob Agents Chemother (1980) 0.86
Revision of HIV center medical staging scale. J Assoc Nurses AIDS Care (1998) 0.85
Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron (1998) 0.85
The risk of hepatitis B among select employee groups in an urban hospital. JAMA (1983) 0.84
Analysis of a hepatitis C screening programme for US veterans. Epidemiol Infect (2006) 0.84
The in-vitro and in-vivo efficacy of cisplatin and analogues in the treatment of herpes simplex virus-II infections. J Antimicrob Chemother (1987) 0.84
A pseudoepidemic of Legionella infections. Chest (1985) 0.83
Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control (1985) 0.83
In vitro susceptibility of gram-positive cocci to paldimycin. Antimicrob Agents Chemother (1987) 0.82
Enterococcus faecalis endocarditis presenting as meningitis. Infection (1999) 0.81
The potential role of respiratory therapy equipment in cross infection. A study using a canine model for pneumonia. Am Rev Respir Dis (1983) 0.80
Nonfatal chromobacterial sepsis. South Med J (1986) 0.80
Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis (1998) 0.79
Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients. AIDS Res Hum Retroviruses (1996) 0.79
Pseudomonas osteomyelitis. Radiologic features. Radiology (1973) 0.79
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population. Rev Infect Dis (1987) 0.79
Activity of quinolones against Legionellaceae. J Antimicrob Chemother (1986) 0.78
Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS (1998) 0.78
Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS (1997) 0.78
Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia. J Clin Microbiol (1996) 0.78
Health care worker exposure to HIV-1 and HTLV I-II in critically ill, resuscitated emergency department patients. Ann Emerg Med (1992) 0.78
The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol (Noisy-le-grand) (1999) 0.78
Comparative biliary concentrations of cephazolin and cephalothin in patients with biliary tract disease. Scott Med J (1976) 0.77
Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients. J Infect Dis (1993) 0.77
Comparison of enzyme-multiplied immunoassay technique with fluorescence polarization immunoassay for determination of gentamicin and tobramycin levels in serum. J Clin Microbiol (1984) 0.77
Feasibility study for neonatal neuroblastoma screening in the United States. Med Pediatr Oncol (1989) 0.77
An outbreak of gentamicin-resistant Klebsiella pneumoniae: analysis of control measures. Infect Control (1984) 0.76
Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. Clin Infect Dis (2001) 0.76
Aseptic meningitis complicating adult Kawasaki disease: case report and review of the literature. Am J Med (1989) 0.76
Disseminated cryptococcosis with muscular involvement. J Infect Dis (1985) 0.76
Evaluation of the insulin jet injector as a potential source of infection. Am J Infect Control (1989) 0.76
Treatment of Legionella pneumophila lung abscess with clindamycin. Clin Infect Dis (1995) 0.76
Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura. Diabet Med (1996) 0.76
Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients. J Acquir Immune Defic Syndr (1994) 0.76
Consider the psychosocial consequences of AIDS. Mich Med (1986) 0.76
Nocardia asteroides aortitis with perforation of the aorta. Hum Pathol (1985) 0.76
Lack of bacterial aerosols associated with heat and moisture exchangers. Am Rev Respir Dis (1986) 0.75
Medical preparation for travel in Africa. J Natl Med Assoc (1983) 0.75
Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol Invest (1995) 0.75
Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. J Clin Microbiol (1984) 0.75
The why and how of physician recruitment. Group Pract (1979) 0.75
Pulmonary complications of AIDS: Henry Ford Hospital experience between January 1984 and July 1986. Henry Ford Hosp Med J (1987) 0.75
AIDS update. Henry Ford Hosp Med J (1987) 0.75
The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit. Henry Ford Hosp Med J (1992) 0.75
Surveillance and management of hospital-acquired infections. Heart Lung (1976) 0.75
Parenteral cephalothin therapy for pelvic gonococcal infections. JACEP (1978) 0.75
T-lymphocyte subset studies to monitor patients with AIDS and AIDS-related complex. Henry Ford Hosp Med J (1987) 0.75
Cost-minimization analysis: A follow-up study of a telemedicine program. Telemed J (1998) 0.75
Filtration of dialysate using an on-line dialysate filter. Int J Artif Organs (1991) 0.75
Caribbean vision care. J Am Optom Assoc (1978) 0.75
Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy. AIDS Res Hum Retroviruses (1993) 0.75
Optometric education in Nigeria. Am J Optom Physiol Opt (1978) 0.75
The clinical spectrum of toxoplasmosis in the adult. Cleve Clin Q (1975) 0.75
Antimicrobial therapy: some guidelines. Heart Lung (1976) 0.75